Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daclatasvir + PegIFN/RBV in HIV/HCV Co-infection
NCT01471574Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2011
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of daclatasvir in hepatitis C (HCV), sponsored by Bristol Myers Squibb. Started Dec 2011; status: completed.
02
Drugs
daclatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01471574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01471574.